<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://m2.mtmt.hu/xsl/gui3.xsl" ?>
<myciteResult>
  <serverUrl>https://m2.mtmt.hu/</serverUrl>
  <labelLang>hun</labelLang>
  <responseDate>2026-09-23 10:26</responseDate>
  <content>
    <publication>
      <otype>JournalArticle</otype>
      <mtid>36216117</mtid>
      <status>ADMIN_APPROVED</status>
      <published>true</published>
      <comment>Funding Agency and Grant Number: Semmelweis University; ELIXIR Hungary
            Funding text: The 4.0 version of ChatGPT, developed by OpenAI, and Gemini, developed by Google, were used as a tool to refine our writing and enhance the clarity of our work. The authors acknowledge the support of ELIXIR Hungary (www.bioinformatics.hu).</comment>
      <unhandledTickets>0</unhandledTickets>
      <deleted>false</deleted>
      <lastRefresh>2026-09-17T19:04:55.449+0000</lastRefresh>
      <lastModified>2026-05-18T14:40:47.944+0000</lastModified>
      <created>2025-06-29T09:36:11.500+0000</created>
      <creator>
        <snippet>true</snippet>
        <mtid>10058020</mtid>
        <familyName>Fekete</familyName>
        <givenName>Mónika</givenName>
        <link>/api/author/10058020</link>
        <otype>Author</otype>
        <label>Fekete Mónika (Népegészségtan)</label>
        <published>true</published>
        <oldId>10058020</oldId>
      </creator>
      <lastDuplumSearch>2026-08-26T14:43:14.141+0000</lastDuplumSearch>
      <adminApproved>2026-04-01T11:50:44.523+0000</adminApproved>
      <adminApprover>
        <snippet>true</snippet>
        <mtid>10093553</mtid>
        <familyName>Fi</familyName>
        <givenName>Tamás</givenName>
        <link>/api/admin/10093553</link>
        <otype>Admin</otype>
        <label>Fi Tamás (SE_AOK_Nepegeszsegtan_Admin5_FT, admin)</label>
        <published>true</published>
      </adminApprover>
      <core>true</core>
      <publicationPending>false</publicationPending>
      <type>
        <snippet>true</snippet>
        <mtid>24</mtid>
        <code>24</code>
        <link>/api/publicationtype/24</link>
        <otype>PublicationType</otype>
        <label>Folyóiratcikk</label>
        <listPosition>1</listPosition>
        <published>true</published>
        <oldId>24</oldId>
        <otypeName>JournalArticle</otypeName>
      </type>
      <subType>
        <snippet>true</snippet>
        <mtid>10000059</mtid>
        <nameEng>Article</nameEng>
        <docType>
          <snippet>true</snippet>
          <mtid>24</mtid>
          <code>24</code>
          <link>/api/publicationtype/24</link>
          <otype>PublicationType</otype>
          <label>Folyóiratcikk</label>
          <listPosition>1</listPosition>
          <published>true</published>
          <oldId>24</oldId>
          <otypeName>JournalArticle</otypeName>
        </docType>
        <link>/api/subtype/10000059</link>
        <name>Szakcikk</name>
        <otype>SubType</otype>
        <label>Szakcikk (Folyóiratcikk)</label>
        <listPosition>101</listPosition>
        <published>true</published>
        <oldId>10000059</oldId>
      </subType>
      <category>
        <snippet>true</snippet>
        <mtid>1</mtid>
        <link>/api/category/1</link>
        <otype>Category</otype>
        <label>Tudományos</label>
        <published>true</published>
        <oldId>1</oldId>
      </category>
      <firstAuthor>Ungvari, Zoltan</firstAuthor>
      <title>PCSK9 expression and cancer survival: a prognostic biomarker at the intersection of oncology and geroscience</title>
      <journal>
        <snippet>true</snippet>
        <sciIndexed>true</sciIndexed>
        <link>/api/journal/10071822</link>
        <reviewType>REVIEWED</reviewType>
        <label>GEROSCIENCE: OFFICIAL JOURNAL OF THE AMERICAN AGING ASSOCIATION (AGE) 2509-2715 2509-2723</label>
        <published>true</published>
        <hungarian>false</hungarian>
        <oldId>10071822</oldId>
        <noIF>false</noIF>
        <mtid>10071822</mtid>
        <scopusIndexed>true</scopusIndexed>
        <pIssn>2509-2715</pIssn>
        <eIssn>2509-2723</eIssn>
        <otype>Journal</otype>
        <lang>FOREIGN</lang>
      </journal>
      <volume>48</volume>
      <issue>1</issue>
      <firstPage>435</firstPage>
      <lastPage>449</lastPage>
      <firstPageOrInternalIdForSort>435</firstPageOrInternalIdForSort>
      <pageLength>15</pageLength>
      <publishedYear>2026</publishedYear>
      <abstractText>Proprotein convertase subtilisin/kexin type 9 (PCSK9) is primarily recognized for its role in cholesterol metabolism; however, emerging evidence suggests it plays a broader role in the regulation of cellular aging mechanisms and the pathogenesis of age-related diseases. Given that cancer is an age-related disease, PCSK9 has garnered attention for its potential impact on tumor progression and patient survival. In this study, we conducted a comprehensive analysis of PCSK9 expression across multiple tumor types, assessing its prognostic significance using RNA sequencing data from The Cancer Genome Atlas (TCGA) and gene expression microarray data from the Gene Expression Omnibus (GEO). Cox proportional hazards regression models and Kaplan–Meier survival analyses were employed to evaluate overall survival (OS) associations. Our findings reveal that elevated PCSK9 expression is associated with improved OS in breast and ovarian cancers, particularly in Luminal B breast cancer subtypes. Conversely, high PCSK9 expression correlates with worse OS in bladder cancer, renal clear cell carcinoma, melanoma, and pancreatic cancer. Notably, while PCSK9 expression is significantly upregulated in melanoma and bladder tumors, it is downregulated in renal clear cell carcinoma, yet relatively higher expression among renal tumors still predicts poorer survival. No significant associations between PCSK9 expression and OS were observed in colon, liver, gastric, lung, prostate, head and neck cancers, or low-grade gliomas in the available datasets.In conclusion, our study identifies PCSK9 as a prognostic biomarker with distinct, tumor-specific survival implications. Its dual role—associating with improved survival in some cancers while correlating with worse outcomes in others—suggests that PCSK9 may influence cancer progression through context-dependent mechanisms. Future research should focus on elucidating the mechanistic underpinnings of these associations and exploring the diagnostic and therapeutic potential of targeting PCSK9 in oncology.</abstractText>
      <fundings>
        <funding>
          <otype>Funding</otype>
          <mtid>2054593</mtid>
          <link>/api/funding/2054593</link>
          <label>(National Institute of Neurological Disorders and Stroke (R01NS100782))</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
        <funding>
          <otype>Funding</otype>
          <mtid>2054594</mtid>
          <link>/api/funding/2054594</link>
          <label>(FK147194)</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
        <funding>
          <otype>Funding</otype>
          <mtid>2054595</mtid>
          <link>/api/funding/2054595</link>
          <label>Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015) Támogató: NKFIH</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
        <funding>
          <otype>Funding</otype>
          <mtid>2054596</mtid>
          <link>/api/funding/2054596</link>
          <label>(TKP2021-NKTA-47)</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
        <funding>
          <otype>Funding</otype>
          <mtid>2054597</mtid>
          <link>/api/funding/2054597</link>
          <label>Nemzeti Kardiovaszkuláris Laboratórium(RRF-2.3.1-21-2022-00003) Támogató: NKFIH</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
        <funding>
          <otype>Funding</otype>
          <mtid>2054598</mtid>
          <link>/api/funding/2054598</link>
          <label>(TKCS-2021/32)</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
      </fundings>
      <digital>true</digital>
      <printed/>
      <sourceYear>2025</sourceYear>
      <foreignEdition>true</foreignEdition>
      <foreignLanguage>true</foreignLanguage>
      <fullPublication>true</fullPublication>
      <conferencePublication>false</conferencePublication>
      <nationalOrigin>true</nationalOrigin>
      <missingAuthor>false</missingAuthor>
      <oaType>GOLD</oaType>
      <oaCheckDate>2026-09-17</oaCheckDate>
      <oaFree>true</oaFree>
      <oaLink>https://doi.org/10.1007/s11357-025-01733-3</oaLink>
      <citationCount>15</citationCount>
      <citationCountUnpublished>0</citationCountUnpublished>
      <citationCountWoOther>15</citationCountWoOther>
      <independentCitCountWoOther>11</independentCitCountWoOther>
      <nationalOriginCitationCount>3</nationalOriginCitationCount>
      <foreignEditionCitationCount>15</foreignEditionCitationCount>
      <doiCitationCount>11</doiCitationCount>
      <wosCitationCount>8</wosCitationCount>
      <scopusCitationCount>8</scopusCitationCount>
      <wosScopusCitationCount>9</wosScopusCitationCount>
      <wosScopusCitationCountWoOther>9</wosScopusCitationCountWoOther>
      <wosScopusIndependentCitationCount>9</wosScopusIndependentCitationCount>
      <wosScopusIndependentCitationCountWoOther>9</wosScopusIndependentCitationCountWoOther>
      <independentCitationCount>11</independentCitationCount>
      <selfCitationCount>4</selfCitationCount>
      <unhandledCitationCount>0</unhandledCitationCount>
      <citingPubCount>15</citingPubCount>
      <independentCitingPubCount>11</independentCitingPubCount>
      <citingPubCountWoOther>15</citingPubCountWoOther>
      <independentCitingPubCountWoOther>11</independentCitingPubCountWoOther>
      <unhandledCitingPubCount>0</unhandledCitingPubCount>
      <citedPubCount>9</citedPubCount>
      <citedCount>9</citedCount>
      <pubStats>
        <types>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <count>11</count>
        </types>
        <types>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <count>4</count>
        </types>
        <types>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <count>0</count>
        </types>
        <types>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <count>0</count>
        </types>
        <types>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <count>0</count>
        </types>
        <types>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <count>0</count>
        </types>
        <types>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <count>0</count>
        </types>
        <citationTypes>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <years>
          <year>2025</year>
          <publicationCount>0</publicationCount>
          <citationCount>5</citationCount>
          <independentCitationCount>3</independentCitationCount>
          <citingPubCount>5</citingPubCount>
          <independentCitingPubCount>3</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2026</year>
          <publicationCount>0</publicationCount>
          <citationCount>10</citationCount>
          <independentCitationCount>8</independentCitationCount>
          <citingPubCount>10</citingPubCount>
          <independentCitingPubCount>8</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
      </pubStats>
      <ratingsForSort>D1</ratingsForSort>
      <hasCitationDuplums>false</hasCitationDuplums>
      <importDuplum>false</importDuplum>
      <importOverwritten>false</importOverwritten>
      <importSkipped>false</importSkipped>
      <userChangeableUntil>2025-09-27T09:36:19.757+0000</userChangeableUntil>
      <directInstitutesForSort>Biofizikai Intézet (PTE / ÁOK); Bioinformatika Tanszék (SE / AOK / I); Doktori Iskola (SE); Megelőző Orvostani és Népegészségtani Intézet  (SE / AOK / I); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI)</directInstitutesForSort>
      <ownerAuthorCount>5</ownerAuthorCount>
      <ownerInstituteCount>47</ownerInstituteCount>
      <directInstituteCount>5</directInstituteCount>
      <authorCount>6</authorCount>
      <contributorCount>0</contributorCount>
      <hasQualityFactor>true</hasQualityFactor>
      <languages>
        <language>
          <otype>Language</otype>
          <mtid>10002</mtid>
          <link>/api/language/10002</link>
          <label>Angol</label>
          <name>Angol</name>
          <nameEng>English</nameEng>
          <published>true</published>
          <oldId>2</oldId>
          <snippet>true</snippet>
        </language>
      </languages>
      <authorships>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127048069</mtid>
          <link>/api/authorship/127048069</link>
          <label>Ungvari, Zoltan [Ungvári, Zoltán István (Orvostudomány, me...), szerző] Megelőző Orvostani és Népegészségtani Intézet  (SE / AOK / I); Doktori Iskola (SE)</label>
          <listPosition>1</listPosition>
          <share>0.167</share>
          <first>true</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10043602</mtid>
            <link>/api/author/10043602</link>
            <label>Ungvári Zoltán István (Orvostudomány, megelőző orvostan, népegészségtan, kórélettan, gerontológia)</label>
            <familyName>Ungvári</familyName>
            <givenName>Zoltán István</givenName>
            <published>true</published>
            <oldId>10043602</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Ungvari</familyName>
          <givenName>Zoltan</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127048070</mtid>
          <link>/api/authorship/127048070</link>
          <label>Menyhart, Otília [Menyhárt, Otília (Onkológia), szerző] Bioinformatika Tanszék (SE / AOK / I); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI)</label>
          <listPosition>2</listPosition>
          <share>0.167</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10045338</mtid>
            <link>/api/author/10045338</link>
            <label>Menyhárt Otília (Onkológia)</label>
            <familyName>Menyhárt</familyName>
            <givenName>Otília</givenName>
            <published>true</published>
            <oldId>10045338</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Menyhart</familyName>
          <givenName>Otília</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127048071</mtid>
          <link>/api/authorship/127048071</link>
          <label>Lehoczki, Andrea ✉ [Lehoczki, Andrea Marianna (hematológia, belg...), szerző] Megelőző Orvostani és Népegészségtani Intézet  (SE / AOK / I); Doktori Iskola (SE)</label>
          <listPosition>3</listPosition>
          <share>0.167</share>
          <first>false</first>
          <last>false</last>
          <corresponding>true</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10089009</mtid>
            <link>/api/author/10089009</link>
            <label>Lehoczki Andrea Marianna (hematológia, belgyógyászat)</label>
            <familyName>Lehoczki</familyName>
            <givenName>Andrea Marianna</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Lehoczki</familyName>
          <givenName>Andrea</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127048072</mtid>
          <link>/api/authorship/127048072</link>
          <label>Fekete, Monika [Fekete, Mónika (Népegészségtan), szerző] Megelőző Orvostani és Népegészségtani Intézet  (SE / AOK / I)</label>
          <listPosition>4</listPosition>
          <share>0.167</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10058020</mtid>
            <link>/api/author/10058020</link>
            <label>Fekete Mónika (Népegészségtan)</label>
            <familyName>Fekete</familyName>
            <givenName>Mónika</givenName>
            <published>true</published>
            <oldId>10058020</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Fekete</familyName>
          <givenName>Monika</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127048073</mtid>
          <link>/api/authorship/127048073</link>
          <label>Bianchini, Giampaolo</label>
          <listPosition>5</listPosition>
          <share>0.16666667</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Bianchini</familyName>
          <givenName>Giampaolo</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127048074</mtid>
          <link>/api/authorship/127048074</link>
          <label>Győrffy, Balázs [Győrffy, Balázs (Onkológia), szerző] Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI); Bioinformatika Tanszék (SE / AOK / I); Biofizikai Intézet (PTE / ÁOK)</label>
          <listPosition>6</listPosition>
          <share>0.167</share>
          <first>false</first>
          <last>true</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10000109</mtid>
            <link>/api/author/10000109</link>
            <label>Győrffy Balázs (Onkológia)</label>
            <familyName>Győrffy</familyName>
            <givenName>Balázs</givenName>
            <published>true</published>
            <oldId>10000109</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Győrffy</familyName>
          <givenName>Balázs</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
      </authorships>
      <identifiers>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>29538175</mtid>
          <link>/api/publicationidentifier/29538175</link>
          <label>DOI: 10.1007/s11357-025-01733-3</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>6</mtid>
            <link>/api/publicationsource/6</link>
            <label>DOI</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10001</mtid>
              <link>/api/publicationsourcetype/10001</link>
              <label>DOI</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>DOI</name>
            <nameEng>DOI</nameEng>
            <linkPattern>https://doi.org/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>6</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>GOLD</oaType>
          <oaFree>true</oaFree>
          <validState>IDENTICAL</validState>
          <idValue>10.1007/s11357-025-01733-3</idValue>
          <realUrl>https://doi.org/10.1007/s11357-025-01733-3</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>29571355</mtid>
          <link>/api/publicationidentifier/29571355</link>
          <label>WoS: 001518302900001</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>1</mtid>
            <link>/api/publicationsource/1</link>
            <label>WoS</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>WoS</name>
            <nameEng>WoS</nameEng>
            <linkPattern>https://www.webofscience.com/wos/woscc/full-record/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>1</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>001518302900001</idValue>
          <realUrl>https://www.webofscience.com/wos/woscc/full-record/001518302900001</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>33047555</mtid>
          <link>/api/publicationidentifier/33047555</link>
          <label>REAL: 246671</label>
          <source>
            <otype>SwordSource</otype>
            <mtid>36</mtid>
            <link>/api/publicationsource/36</link>
            <label>REAL</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10007</mtid>
              <link>/api/publicationsourcetype/10007</link>
              <label>Repozitórium</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>REAL</name>
            <nameEng>REAL</nameEng>
            <linkPattern>https://real.mtak.hu/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>36</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>GOLD</oaType>
          <oaFree>true</oaFree>
          <idValue>246671</idValue>
          <realUrl>https://real.mtak.hu/246671</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>29571356</mtid>
          <link>/api/publicationidentifier/29571356</link>
          <label>Scopus: 105009094271</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>3</mtid>
            <link>/api/publicationsource/3</link>
            <label>Scopus</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Scopus</name>
            <nameEng>Scopus</nameEng>
            <linkPattern>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>3</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>105009094271</idValue>
          <realUrl>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-105009094271</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>29538537</mtid>
          <link>/api/publicationidentifier/29538537</link>
          <label>PubMed: 40576911</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>17</mtid>
            <link>/api/publicationsource/17</link>
            <label>PubMed</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>PubMed</name>
            <nameEng>PubMed</nameEng>
            <linkPattern>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=@@@&amp;dopt=Abstract</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>17</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>40576911</idValue>
          <realUrl>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=40576911&amp;dopt=Abstract</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>31388884</mtid>
          <link>/api/publicationidentifier/31388884</link>
          <label>Egyéb URL: https://link.springer.com/10.1007/s11357-025-01733-3</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>40</mtid>
            <link>/api/publicationsource/40</link>
            <label>Egyéb URL</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10006</mtid>
              <link>/api/publicationsourcetype/10006</link>
              <label>Link</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Egyéb URL</name>
            <nameEng>Other URL</nameEng>
            <linkPattern>@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>40</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>https://link.springer.com/10.1007/s11357-025-01733-3</idValue>
          <realUrl>https://link.springer.com/10.1007/s11357-025-01733-3</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>32201238</mtid>
          <link>/api/publicationidentifier/32201238</link>
          <label>Egyéb URL: https://www.scopus.com/pages/publications/105009094271?origin=resultslist</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>40</mtid>
            <link>/api/publicationsource/40</link>
            <label>Egyéb URL</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10006</mtid>
              <link>/api/publicationsourcetype/10006</link>
              <label>Link</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Egyéb URL</name>
            <nameEng>Other URL</nameEng>
            <linkPattern>@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>40</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>NONE</oaType>
          <validState>IDENTICAL</validState>
          <idValue>https://www.scopus.com/pages/publications/105009094271?origin=resultslist</idValue>
          <realUrl>https://www.scopus.com/pages/publications/105009094271?origin=resultslist</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
      </identifiers>
      <subjects>
        <classification>
          <otype>Classification</otype>
          <mtid>12306</mtid>
          <link>/api/classification/12306</link>
          <label>Onkológia</label>
          <published>true</published>
          <snippet>true</snippet>
        </classification>
      </subjects>
      <files>
        <file>
          <otype>UploadedFile</otype>
          <mtid>983678</mtid>
          <link>/api/uploadedfile/983678</link>
          <label>PCSK9.pdf (1424kB)</label>
          <published>false</published>
          <snippet>true</snippet>
        </file>
      </files>
      <ratings>
        <rating>
          <otype>SjrRating</otype>
          <mtid>11734232</mtid>
          <link>/api/sjrrating/11734232</link>
          <label>sjr:D1 (2026) Scopus - Veterinary (miscellaneous) GEROSCIENCE: OFFICIAL JOURNAL OF THE AMERICAN AGING ASSOCIATION (AGE) 2509-2715 2509-2723</label>
          <listPos>2</listPos>
          <rankValue>0.0</rankValue>
          <type>journal</type>
          <ratingType>
            <otype>RatingType</otype>
            <mtid>10002</mtid>
            <link>/api/ratingtype/10002</link>
            <label>sjr</label>
            <code>sjr</code>
            <published>true</published>
            <snippet>true</snippet>
          </ratingType>
          <subject>
            <otype>ClassificationExternal</otype>
            <mtid>3401</mtid>
            <link>/api/classificationexternal/3401</link>
            <label>Scopus - Veterinary (miscellaneous)</label>
            <published>true</published>
            <oldId>3401</oldId>
            <snippet>true</snippet>
          </subject>
          <ranking>D1</ranking>
          <calculation>FROM_LAST_YEAR</calculation>
          <published>true</published>
          <snippet>true</snippet>
        </rating>
      </ratings>
      <references>
        <reference>
          <otype>Reference</otype>
          <mtid>66624321</mtid>
          <link>/api/reference/66624321</link>
          <label>1. Fekete M, Major D, Feher A, Fazekas-Pongor V, Lehoczki A. Geroscience and pathology: a new frontier in understanding age-related diseases. Pathol Oncol Res. 2024: https://doi.org/10.3389/pore.2024.1611623., DOI: 10.3389/pore.2024.1611623</label>
          <listPosition>1</listPosition>
          <doi>10.3389/pore.2024.1611623</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624322</mtid>
          <link>/api/reference/66624322</link>
          <label>2. Seidah NG, Prat A. The Multifaceted Biology of PCSK9. Endocr Rev. 2022;43:558–82. https://doi.org/10.1210/endrev/bnab035., DOI: 10.1210/endrev/bnab035</label>
          <listPosition>2</listPosition>
          <doi>10.1210/endrev/bnab035</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624323</mtid>
          <link>/api/reference/66624323</link>
          <label>3. Nejabat M, Hadizadeh F, Almahmeed W, Sahebkar A. Effects of PCSK9 inhibitors on cancer, diabetes, and cardiovascular diseases. Drug Discov Today. 2025;30: 104316. https://doi.org/10.1016/j.drudis.2025.104316., DOI: 10.1016/j.drudis.2025.104316</label>
          <listPosition>3</listPosition>
          <doi>10.1016/j.drudis.2025.104316</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624324</mtid>
          <link>/api/reference/66624324</link>
          <label>4. Csiszar A, Tarantini S, Yabluchanskiy A, Ungvari Z. PCSK9: an emerging player in cardiometabolic aging and its potential as a therapeutic target and biomarker. Geroscience. 2024;46:257–63. https://doi.org/10.1007/s11357-023-01003-0., DOI: 10.1007/s11357-023-01003-0</label>
          <listPosition>4</listPosition>
          <doi>10.1007/s11357-023-01003-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624325</mtid>
          <link>/api/reference/66624325</link>
          <label>5. Seidah NG, Garcon D. Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond. Curr Atheroscler Rep. 2022;24:821–30. https://doi.org/10.1007/s11883-022-01057-z., DOI: 10.1007/s11883-022-01057-z</label>
          <listPosition>5</listPosition>
          <doi>10.1007/s11883-022-01057-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624326</mtid>
          <link>/api/reference/66624326</link>
          <label>6. Seidah NG, Awan Z, Chretien M, Mbikay M. PCSK9: a key modulator of cardiovascular health. Circ Res. 2014;114:1022–36. https://doi.org/10.1161/CIRCRESAHA.114.301621., DOI: 10.1161/CIRCRESAHA.114.301621</label>
          <listPosition>6</listPosition>
          <doi>10.1161/CIRCRESAHA.114.301621</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624327</mtid>
          <link>/api/reference/66624327</link>
          <label>7. Barbati G, Gregorio C, Scagnetto A, Indennidate C, Cappelletto C, Di Lenarda A. Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records. PLoS ONE. 2024;19:e0309470. https://doi.org/10.1371/journal.pone.0309470., DOI: 10.1371/journal.pone.0309470</label>
          <listPosition>7</listPosition>
          <doi>10.1371/journal.pone.0309470</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624328</mtid>
          <link>/api/reference/66624328</link>
          <label>8. Matyas C, Trojnar E, Zhao S, Arif M, Mukhopadhyay P, Kovács A, Fabian A, Tokodi M, Bagyura Z, Merkely B, Kohidai L, Lajko E, Takacs A, He Y, Gao B, Paloczi J, Lohoff F, Hasko G, Ding W, Pacher P. PCSK9, a promising novel target for age-related cardiovascular dysfunction. JACC Basic Transl Sci. 2023;8(10):1334-53. https://doi.org/10.1016/j.jacbts.2023.06.005., DOI: 10.1016/j.jacbts.2023.06.005</label>
          <listPosition>8</listPosition>
          <doi>10.1016/j.jacbts.2023.06.005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624329</mtid>
          <link>/api/reference/66624329</link>
          <label>9. Arif M, Matyas C, Mukhopadhyay P, Yokus B, Trojnar E, Paloczi J, Paes-Leme B, Zhao S, Lohoff FW, Hasko G, Pacher P. Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver aging. Geroscience. 2023. https://doi.org/10.1007/s11357-023-00928-w., DOI: 10.1007/s11357-023-00928-w</label>
          <listPosition>9</listPosition>
          <doi>10.1007/s11357-023-00928-w</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624330</mtid>
          <link>/api/reference/66624330</link>
          <label>10. Oza PP, Kashfi K. The evolving landscape of PCSK9 inhibition in cancer. Eur J Pharmacol. 2023;949: 175721. https://doi.org/10.1016/j.ejphar.2023.175721., DOI: 10.1016/j.ejphar.2023.175721</label>
          <listPosition>10</listPosition>
          <doi>10.1016/j.ejphar.2023.175721</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624331</mtid>
          <link>/api/reference/66624331</link>
          <label>11. Mei W, Faraj Tabrizi S, Godina C, Lovisa AF, Isaksson K, Jernstrom H, Tavazoie SF. A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor. Cell. 2025;188(371–389): e328. https://doi.org/10.1016/j.cell.2024.11.009., DOI: 10.1016/j.cell.2024.11.009</label>
          <listPosition>11</listPosition>
          <doi>10.1016/j.cell.2024.11.009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624332</mtid>
          <link>/api/reference/66624332</link>
          <label>12. Wang H, Shao Z. PCSK9 V474I germline variant drives breast cancer metastasis. Life Metab. 2025;4:loae041. https://doi.org/10.1093/lifemeta/loae041, DOI: 10.1093/lifemeta/loae041</label>
          <listPosition>12</listPosition>
          <doi>10.1093/lifemeta/loae041</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624333</mtid>
          <link>/api/reference/66624333</link>
          <label>13. Sun H, Meng W, Zhu J, Wang L. Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition. Naunyn Schmiedebergs Arch Pharmacol. 2022;395:643–58. https://doi.org/10.1007/s00210-022-02200-y., DOI: 10.1007/s00210-022-02200-y</label>
          <listPosition>13</listPosition>
          <doi>10.1007/s00210-022-02200-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624334</mtid>
          <link>/api/reference/66624334</link>
          <label>14. Zhou S, Guo Q, Chen A, Li X, Zou X. Integrated bioinformatics analysis identifies PCSK9 as a prognosticator correlated with lipid metabolism in pancreatic adenocarcinoma. World J Surg Oncol. 2024;22:256. https://doi.org/10.1186/s12957-024-03532-0., DOI: 10.1186/s12957-024-03532-0</label>
          <listPosition>14</listPosition>
          <doi>10.1186/s12957-024-03532-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624335</mtid>
          <link>/api/reference/66624335</link>
          <label>15. Hsu CY, Abdulrahim MN, Mustafa MA, Omar TM, Balto F, Pineda I, Khudair TT, Ubaid M, Ali MS. The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy. Med Oncol. 2024;41:202. https://doi.org/10.1007/s12032-024-02435-0., DOI: 10.1007/s12032-024-02435-0</label>
          <listPosition>15</listPosition>
          <doi>10.1007/s12032-024-02435-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624336</mtid>
          <link>/api/reference/66624336</link>
          <label>16. Sun S, Yang Z, Yao H, Zhang Z. A new enhancer for anti-PD-1/PD-L1 immunotherapy: PCSK9 inhibition. Trends Cancer. 2025;11:84–7. https://doi.org/10.1016/j.trecan.2024.10.002., DOI: 10.1016/j.trecan.2024.10.002</label>
          <listPosition>16</listPosition>
          <doi>10.1016/j.trecan.2024.10.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624337</mtid>
          <link>/api/reference/66624337</link>
          <label>17. Liu X, Bao X, Hu M, Chang H, Jiao M, Cheng J, Xie L, Huang Q, Li F, Li CY. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature. 2020;588:693–8. https://doi.org/10.1038/s41586-020-2911-7., DOI: 10.1038/s41586-020-2911-7</label>
          <listPosition>17</listPosition>
          <doi>10.1038/s41586-020-2911-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624338</mtid>
          <link>/api/reference/66624338</link>
          <label>18. Sun C, Zhu G, Shen C, Huang S, Li R, Li J, Ma Z, Wang Z. Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis. Front Oncol. 2023;13:1134063. https://doi.org/10.3389/fonc.2023.1134063., DOI: 10.3389/fonc.2023.1134063</label>
          <listPosition>18</listPosition>
          <doi>10.3389/fonc.2023.1134063</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624339</mtid>
          <link>/api/reference/66624339</link>
          <label>19. Wang W, Li W, Zhang D, Mi Y, Zhang J, He G. The Causal Relationship between PCSK9 Inhibitors and Malignant Tumors: A Mendelian Randomization Study Based on Drug Targeting. Genes (Basel). 2024;15. https://doi.org/10.3390/genes15010132, DOI: 10.3390/genes15010132</label>
          <listPosition>19</listPosition>
          <doi>10.3390/genes15010132</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624340</mtid>
          <link>/api/reference/66624340</link>
          <label>20. Bhat M, Skill N, Marcus V, Deschenes M, Tan X, Bouteaud J, Negi S, Awan Z, Aikin R, Kwan J, Amre R, Tabaries S, Hassanain M, Seidah NG, Maluccio M, Siegel P, Metrakos P. Decreased PCSK9 expression in human hepatocellular carcinoma. BMC Gastroenterol. 2015;15:176. https://doi.org/10.1186/s12876-015-0371-6., DOI: 10.1186/s12876-015-0371-6</label>
          <listPosition>20</listPosition>
          <doi>10.1186/s12876-015-0371-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624341</mtid>
          <link>/api/reference/66624341</link>
          <label>21. Bonaventura A, Grossi F, Montecucco F. PCSK9 is a promising prognostic marker in patients with advanced NSCLC. Cancer Immunol Immunother. 2020;69:491–2. https://doi.org/10.1007/s00262-020-02485-z., DOI: 10.1007/s00262-020-02485-z</label>
          <listPosition>21</listPosition>
          <doi>10.1007/s00262-020-02485-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624342</mtid>
          <link>/api/reference/66624342</link>
          <label>22. Wong CC, Wu JL, Ji F, Kang W, Bian X, Chen H, Chan LS, Luk STY, Tong S, Xu J, Zhou Q, Liu D, Su H, Gou H, Cheung AH, To KF, Cai Z, Shay JW, Yu J. The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer. Nat Commun. 2022;13:3971. https://doi.org/10.1038/s41467-022-31663-z., DOI: 10.1038/s41467-022-31663-z</label>
          <listPosition>22</listPosition>
          <doi>10.1038/s41467-022-31663-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624343</mtid>
          <link>/api/reference/66624343</link>
          <label>23. Wong Chong E, Joncas FH, Seidah NG, Calon F, Diorio C, Gangloff A. Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers. BMC Cancer. 2022;22:1049. https://doi.org/10.1186/s12885-022-10120-6., DOI: 10.1186/s12885-022-10120-6</label>
          <listPosition>23</listPosition>
          <doi>10.1186/s12885-022-10120-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624344</mtid>
          <link>/api/reference/66624344</link>
          <label>24. Fang S, Yarmolinsky J, Gill D, Bull CJ, Perks CM, Consortium P, Davey Smith G, Gaunt TR, Richardson TG. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study. PLoS Med. 2023;20:e1003988. https://doi.org/10.1371/journal.pmed.1003988, DOI: 10.1371/journal.pmed.1003988</label>
          <listPosition>24</listPosition>
          <doi>10.1371/journal.pmed.1003988</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624345</mtid>
          <link>/api/reference/66624345</link>
          <label>25. Wang H, Guo Q, Wang M, Liu C, Tian Z. PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma. Oncol Lett. 2023;26:500. https://doi.org/10.3892/ol.2023.14086., DOI: 10.3892/ol.2023.14086</label>
          <listPosition>25</listPosition>
          <doi>10.3892/ol.2023.14086</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624346</mtid>
          <link>/api/reference/66624346</link>
          <label>26. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106. https://doi.org/10.1186/gb-2010-11-10-r106., DOI: 10.1186/gb-2010-11-10-r106</label>
          <listPosition>26</listPosition>
          <doi>10.1186/gb-2010-11-10-r106</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624347</mtid>
          <link>/api/reference/66624347</link>
          <label>27. Gyorffy B, Molnar B, Lage H, Szallasi Z, Eklund AC. Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS ONE. 2009;4: e5645. https://doi.org/10.1371/journal.pone.0005645., DOI: 10.1371/journal.pone.0005645</label>
          <listPosition>27</listPosition>
          <doi>10.1371/journal.pone.0005645</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624348</mtid>
          <link>/api/reference/66624348</link>
          <label>28. Gyorffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023;45:1889–98. https://doi.org/10.1007/s11357-023-00742-4., DOI: 10.1007/s11357-023-00742-4</label>
          <listPosition>28</listPosition>
          <doi>10.1007/s11357-023-00742-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624349</mtid>
          <link>/api/reference/66624349</link>
          <label>29. Bartha A, Gyorffy B. TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int J Mol Sci. 2021;22. https://doi.org/10.3390/ijms22052622, DOI: 10.3390/ijms22052622</label>
          <listPosition>29</listPosition>
          <doi>10.3390/ijms22052622</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624350</mtid>
          <link>/api/reference/66624350</link>
          <label>30. Antipenko ID, Olkhovik DM, Solopova ON, Khayretdinova GA, Kalacheva OS, Makarova JA, Shkurnikov MY. The Expression of the LDLR, LDLRAP1, and PCSK9 Genes has Prognostic Significance in Triple-negative Breast Cancer. Curr Med Chem. 2025. https://doi.org/10.2174/0109298673291217241219055416., DOI: 10.2174/0109298673291217241219055416</label>
          <listPosition>30</listPosition>
          <doi>10.2174/0109298673291217241219055416</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624351</mtid>
          <link>/api/reference/66624351</link>
          <label>31. Gu Y, Lin X, Dong Y, Wood G, Seidah NG, Werstuck G, Major P, Bonert M, Kapoor A, Tang D. PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity. J Exp Clin Cancer Res. 2023;42:2. https://doi.org/10.1186/s13046-022-02584-y., DOI: 10.1186/s13046-022-02584-y</label>
          <listPosition>31</listPosition>
          <doi>10.1186/s13046-022-02584-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624352</mtid>
          <link>/api/reference/66624352</link>
          <label>32. Zhang SZ, Zhu XD, Feng LH, Li XL, Liu XF, Sun HC, Tang ZY. PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma. Exp Hematol Oncol. 2021;10:25. https://doi.org/10.1186/s40164-021-00218-1., DOI: 10.1186/s40164-021-00218-1</label>
          <listPosition>32</listPosition>
          <doi>10.1186/s40164-021-00218-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624353</mtid>
          <link>/api/reference/66624353</link>
          <label>33. Wang L, Li S, Luo H, Lu Q, Yu S. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages. J Exp Clin Cancer Res. 2022;41:303. https://doi.org/10.1186/s13046-022-02477-0., DOI: 10.1186/s13046-022-02477-0</label>
          <listPosition>33</listPosition>
          <doi>10.1186/s13046-022-02477-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624354</mtid>
          <link>/api/reference/66624354</link>
          <label>34. Hu J, Zhang M, Gui L, Wan Q, Zhong J, Bai L, He M. PCSK9 Suppresses M2-Like Tumor-Associated Macrophage Polarization by Regulating the Secretion of OX40L from Hepatocellular Carcinoma Cells. Immunol Invest. 2022;51:1678–93. https://doi.org/10.1080/08820139.2022.2027439., DOI: 10.1080/08820139.2022.2027439</label>
          <listPosition>34</listPosition>
          <doi>10.1080/08820139.2022.2027439</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624355</mtid>
          <link>/api/reference/66624355</link>
          <label>35. Li Y, Chen Y, Zhao C, Yang Y, Zhang M, Cheng H, Li Q, Wang M. Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression. Phytomedicine. 2024;128: 155532. https://doi.org/10.1016/j.phymed.2024.155532., DOI: 10.1016/j.phymed.2024.155532</label>
          <listPosition>35</listPosition>
          <doi>10.1016/j.phymed.2024.155532</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624356</mtid>
          <link>/api/reference/66624356</link>
          <label>36. Wang H, Zhang X, Zhang Y, Shi T, Zhang Y, Song X, Liu B, Wang Y, Wei J. Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy. BMC Cancer. 2024;24:445. https://doi.org/10.1186/s12885-024-12148-2., DOI: 10.1186/s12885-024-12148-2</label>
          <listPosition>36</listPosition>
          <doi>10.1186/s12885-024-12148-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624357</mtid>
          <link>/api/reference/66624357</link>
          <label>37. Yang QC, Wang S, Liu YT, Song A, Wu ZZ, Wan SC, Li HM, Sun ZJ. Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer. iScience. 2023;26:106916. https://doi.org/10.1016/j.isci.2023.106916, DOI: 10.1016/j.isci.2023.106916</label>
          <listPosition>37</listPosition>
          <doi>10.1016/j.isci.2023.106916</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624358</mtid>
          <link>/api/reference/66624358</link>
          <label>38. Xu W, Hu M, Lu X, Lao Y, Ma N, Wang Y, Li J, Chen X, Liu S, Liu J, Zhu W, Yang H. Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy. Int J Biol Sci. 2024;20:3942–55. https://doi.org/10.7150/ijbs.93668., DOI: 10.7150/ijbs.93668</label>
          <listPosition>38</listPosition>
          <doi>10.7150/ijbs.93668</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624359</mtid>
          <link>/api/reference/66624359</link>
          <label>39. Gao X, Yi L, Jiang C, Li S, Wang X, Yang B, Li W, Che N, Wang J, Zhang H, Zhang S. PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer. Front Immunol. 2023;14:1142428. https://doi.org/10.3389/fimmu.2023.1142428., DOI: 10.3389/fimmu.2023.1142428</label>
          <listPosition>39</listPosition>
          <doi>10.3389/fimmu.2023.1142428</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624360</mtid>
          <link>/api/reference/66624360</link>
          <label>40. Wang R, Liu H, He P, An D, Guo X, Zhang X, Feng M. Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8(+) T cells and the exclusion of Treg cells. Front Immunol. 2022;13: 947756. https://doi.org/10.3389/fimmu.2022.947756., DOI: 10.3389/fimmu.2022.947756</label>
          <listPosition>40</listPosition>
          <doi>10.3389/fimmu.2022.947756</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624361</mtid>
          <link>/api/reference/66624361</link>
          <label>41. Ungvari Z. PCSK9 Inhibition: A Novel Approach to Attenuate Cardiovascular and Liver Aging. JACC Basic Transl Sci. 2023;8:1354–6. https://doi.org/10.1016/j.jacbts.2023.08.004., DOI: 10.1016/j.jacbts.2023.08.004</label>
          <listPosition>41</listPosition>
          <doi>10.1016/j.jacbts.2023.08.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624362</mtid>
          <link>/api/reference/66624362</link>
          <label>42. Liu S, Wu J, Stolarz A, Zhang H, Boerma M, Byrum SD, Rusch NJ, Ding Z. PCSK9 attenuates efferocytosis in endothelial cells and promotes vascular aging. Theranostics. 2023;13:2914–29. https://doi.org/10.7150/thno.83914., DOI: 10.7150/thno.83914</label>
          <listPosition>42</listPosition>
          <doi>10.7150/thno.83914</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624363</mtid>
          <link>/api/reference/66624363</link>
          <label>43. Park LM, Pacher P, Lohoff FW. Targeting Oxidative Stress in Neurodegenerative Disorders: A Novel Role for PCSK9 Inhibition? ACS Chem Neurosci. 2024;15:2662–4. https://doi.org/10.1021/acschemneuro.4c00299., DOI: 10.1021/acschemneuro.4c00299</label>
          <listPosition>43</listPosition>
          <doi>10.1021/acschemneuro.4c00299</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624364</mtid>
          <link>/api/reference/66624364</link>
          <label>44. Cammisotto V, Baratta F, Simeone PG, Barale C, Lupia E, Galardo G, Santilli F, Russo I, Pignatelli P. Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis. Antioxidants (Basel). 2022;11. https://doi.org/10.3390/antiox11030569, DOI: 10.3390/antiox11030569</label>
          <listPosition>44</listPosition>
          <doi>10.3390/antiox11030569</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624365</mtid>
          <link>/api/reference/66624365</link>
          <label>45. Guo Y, Tang Z, Yan B, Yin H, Tai S, Peng J, Cui Y, Gui Y, Belke D, Zhou S, Zheng XL. PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular Smooth Muscle Cell Senescence and Apoptosis: Implication of Its Direct Role in Degenerative Vascular Disease. Arterioscler Thromb Vasc Biol. 2022;42:67–86. https://doi.org/10.1161/ATVBAHA.121.316902., DOI: 10.1161/ATVBAHA.121.316902</label>
          <listPosition>45</listPosition>
          <doi>10.1161/ATVBAHA.121.316902</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624366</mtid>
          <link>/api/reference/66624366</link>
          <label>46. Scalambra L, Ruzzi F, Pittino OM, Semprini MS, Cappello C, Angelicola S, Palladini A, Nanni P, Goksoyr L, Fougeroux C, Penichet ML, Sander AF, Lollini PL. Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma. J Transl Med. 2025;23:136. https://doi.org/10.1186/s12967-025-06126-w., DOI: 10.1186/s12967-025-06126-w</label>
          <listPosition>46</listPosition>
          <doi>10.1186/s12967-025-06126-w</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624367</mtid>
          <link>/api/reference/66624367</link>
          <label>47. Bonaventura A, Grossi F, Carbone F, Vecchie A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Rossi G, Biello F, Tagliamento M, Alama A, Coco S, Spallarossa P, Dallegri F, Genova C, Montecucco F. Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. Cancer Immunol Immunother. 2019;68:1351–8. https://doi.org/10.1007/s00262-019-02367-z., DOI: 10.1007/s00262-019-02367-z</label>
          <listPosition>47</listPosition>
          <doi>10.1007/s00262-019-02367-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624368</mtid>
          <link>/api/reference/66624368</link>
          <label>48. Boyer M, Levesque V, Poirier P, Marette A, Mathieu P, Despres JP, Larose E, Arsenault BJ. Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease. J Clin Lipidol. 2016;10:1353–61. https://doi.org/10.1016/j.jacl.2016.08.014., DOI: 10.1016/j.jacl.2016.08.014</label>
          <listPosition>48</listPosition>
          <doi>10.1016/j.jacl.2016.08.014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624369</mtid>
          <link>/api/reference/66624369</link>
          <label>49. Arsenault BJ, Pelletier-Beaumont E, Almeras N, Tremblay A, Poirier P, Bergeron J, Despres JP. PCSK9 levels in abdominally obese men: association with cardiometabolic risk profile and effects of a one-year lifestyle modification program. Atherosclerosis. 2014;236:321–6. https://doi.org/10.1016/j.atherosclerosis.2014.07.010., DOI: 10.1016/j.atherosclerosis.2014.07.010</label>
          <listPosition>49</listPosition>
          <doi>10.1016/j.atherosclerosis.2014.07.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624370</mtid>
          <link>/api/reference/66624370</link>
          <label>50. Wen S, Jadhav KS, Williamson DL, Rideout TC. Treadmill Exercise Training Modulates Hepatic Cholesterol Metabolism and Circulating PCSK9 Concentration in High-Fat-Fed Mice. J Lipids. 2013;2013: 908048. https://doi.org/10.1155/2013/908048., DOI: 10.1155/2013/908048</label>
          <listPosition>50</listPosition>
          <doi>10.1155/2013/908048</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624371</mtid>
          <link>/api/reference/66624371</link>
          <label>51. Li W, Park H, Guo E, Jo W, Sim KM, Lee SK. Aerobic Exercise Training Inhibits Neointimal Formation via Reduction of PCSK9 and LOX-1 in Atherosclerosis. Biomedicines. 2020;8. https://doi.org/10.3390/biomedicines8040092, DOI: 10.3390/biomedicines8040092</label>
          <listPosition>51</listPosition>
          <doi>10.3390/biomedicines8040092</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66624372</mtid>
          <link>/api/reference/66624372</link>
          <label>52. Farahnak Z, Chapados N, Lavoie JM. Exercise training increased gene expression of LDL-R and PCSK9 in intestine: link to transintestinal cholesterol excretion. Gen Physiol Biophys. 2018;37:309–17. https://doi.org/10.4149/gpb_2017047., DOI: 10.4149/gpb_2017047</label>
          <listPosition>52</listPosition>
          <doi>10.4149/gpb_2017047</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
      </references>
      <link>/api/publication/36216117</link>
      <label>Ungvari Zoltan et al. PCSK9 expression and cancer survival: a prognostic biomarker at the intersection of oncology and geroscience. (2026) GEROSCIENCE: OFFICIAL JOURNAL OF THE AMERICAN AGING ASSOCIATION (AGE) 2509-2715 2509-2723 48 1 435-449</label><template>&lt;div class=&quot;JournalArticle Publication short-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;span class=&quot;author-name&quot; mtid=&quot;10043602&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10043602&quot; target=&quot;_blank&quot;&gt;Ungvari, Zoltan&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10045338&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10045338&quot; target=&quot;_blank&quot;&gt;Menyhart, Otília&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10089009&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10089009&quot; target=&quot;_blank&quot;&gt;Lehoczki, Andrea ✉&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10058020&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10058020&quot; target=&quot;_blank&quot;&gt;Fekete, Monika&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Bianchini, Giampaolo &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10000109&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10000109&quot; target=&quot;_blank&quot;&gt;Győrffy, Balázs&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; &lt;/div &gt;&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;36216117&quot; mtid=&quot;36216117&quot; target=&quot;_blank&quot;&gt;PCSK9 expression and cancer survival: a prognostic biomarker at the intersection of oncology and geroscience&lt;/a&gt;&lt;/div&gt; &lt;div class=&quot;pub-info&quot;&gt; &lt;span class=&quot;journal-title&quot;&gt;GEROSCIENCE: OFFICIAL JOURNAL OF THE AMERICAN AGING ASSOCIATION (AGE)&lt;/span&gt; &lt;span class=&quot;journal-volume&quot;&gt;48&lt;/span&gt; : &lt;span class=&quot;journal-issue&quot;&gt;1&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; pp. 435-449. , 15 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2026)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-end&quot;&gt;&lt;div class=&quot;identifier-list&quot;&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.1007/s11357-025-01733-3&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1007/s11357-025-01733-3&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;001518302900001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001518302900001&quot;&gt; WoS &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:black&quot; title=&quot;246671&quot; target=&quot;_blank&quot; href=&quot;https://real.mtak.hu/246671&quot;&gt; REAL &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;105009094271&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-105009094271&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;40576911&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=40576911&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;https://link.springer.com/10.1007/s11357-025-01733-3&quot; target=&quot;_blank&quot; href=&quot;https://link.springer.com/10.1007/s11357-025-01733-3&quot;&gt; Egyéb URL &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_NONE&quot; title=&quot; Nincs &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;https://www.scopus.com/pages/publications/105009094271?origin=resultslist&quot; target=&quot;_blank&quot; href=&quot;https://www.scopus.com/pages/publications/105009094271?origin=resultslist&quot;&gt; Egyéb URL &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;short-pub-prop-list&quot;&gt; &lt;span class=&quot;short-pub-mtid&quot;&gt; Közlemény:36216117 &lt;/span&gt; &lt;span class=&quot;status-holder&quot;&gt;&lt;span class=&quot;status-data status-ADMIN_APPROVED&quot;&gt; Admin láttamozott &lt;/span&gt;&lt;/span&gt; &lt;span class=&quot;pub-core&quot;&gt;Forrás Idéző &lt;/span&gt; &lt;span class=&quot;pub-type&quot;&gt;Folyóiratcikk (Szakcikk ) &lt;/span&gt; &lt;!-- &amp;&amp; !record.category.scientific --&gt; &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 15&lt;/span&gt; | Független: 11 | Függő: 4 | Nem jelölt: 0 | WoS jelölt: 8 | Scopus jelölt:&amp;nbsp;8 | WoS/Scopus jelölt:&amp;nbsp;9 | DOI jelölt:&amp;nbsp;11 &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;</template><template2>&lt;div class=&quot;JournalArticle Publication long-list&quot;&gt;
&lt;div class=&quot;authors&quot;&gt;
	&lt;img title=&quot;Forrásközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-core-icon.png&quot;&gt;
	&lt;img title=&quot;Idézőközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-citation-icon.png&quot;&gt;

		&lt;div class=&quot;autype autype0&quot;&gt;				&lt;span class=&quot;author-name&quot; mtid=&quot;10043602&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10043602&quot; target=&quot;_blank&quot;&gt;Ungvari Zoltan
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Ungvári Zoltán István&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Orvostudomány, megelőző orvostan, népegészségta...&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Megelőző Orvostani és Népegészségtani Intézet ; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/Doktori Iskola&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10045338&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10045338&quot; target=&quot;_blank&quot;&gt;Menyhart Otília
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Menyhárt Otília&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Onkológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Bioinformatika Tanszék; &lt;span title=&quot;HUN-REN Természettudományi Kutatóközpont&quot;&gt;HRN TTK&lt;/span&gt;/&lt;span title=&quot;Molekuláris Élettudományi Intézet&quot;&gt;MÉI&lt;/span&gt;/Onkológiai Biomarker Kutatócsoport (Lendület)&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10089009&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10089009&quot; target=&quot;_blank&quot;&gt;Lehoczki Andrea ✉
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Lehoczki Andrea Marianna&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; hematológia, belgyógyászat&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Megelőző Orvostani és Népegészségtani Intézet ; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/Doktori Iskola&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10058020&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10058020&quot; target=&quot;_blank&quot;&gt;Fekete Monika
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Fekete Mónika&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Népegészségtan&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Megelőző Orvostani és Népegészségtani Intézet &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Bianchini Giampaolo
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10000109&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10000109&quot; target=&quot;_blank&quot;&gt;Győrffy Balázs
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Győrffy Balázs&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Onkológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;HUN-REN Természettudományi Kutatóközpont&quot;&gt;HRN TTK&lt;/span&gt;/&lt;span title=&quot;Molekuláris Élettudományi Intézet&quot;&gt;MÉI&lt;/span&gt;/Onkológiai Biomarker Kutatócsoport (Lendület); &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Bioinformatika Tanszék; &lt;span title=&quot;Pécsi Tudományegyetem&quot;&gt;PTE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;ÁOK&lt;/span&gt;/Biofizikai Intézet&lt;/span&gt;

				    &lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;36216117&quot; target=&quot;_blank&quot;&gt;PCSK9 expression and cancer survival: a prognostic biomarker at the intersection of oncology and geroscience&lt;/a&gt;&lt;/div&gt;    &lt;div&gt;		&lt;span class=&quot;journal-title&quot;&gt;GEROSCIENCE: OFFICIAL JOURNAL OF THE AMERICAN AGING ASSOCIATION (AGE)&lt;/span&gt;

        &lt;span class=&quot;journal-issn&quot;&gt;(&lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/2509-2715&quot;&gt;2509-2715&lt;/a&gt; &lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/2509-2723&quot;&gt;2509-2723&lt;/a&gt;)&lt;/span&gt;:
		&lt;span class=&quot;journal-volume&quot;&gt;48&lt;/span&gt; &lt;span class=&quot;journal-issue&quot;&gt;1&lt;/span&gt;
&lt;span class=&quot;page&quot;&gt;
	pp 435-449
			
&lt;/span&gt;		 &lt;span class=&quot;year&quot;&gt;(2026)&lt;/span&gt;  
    &lt;/div&gt;
&lt;div class=&quot;pub-footer&quot;&gt;
    

	&lt;span class=&quot;language&quot; xmlns=&quot;http://www.w3.org/1999/html&quot;&gt;Nyelv:
			Angol
		 |  &lt;/span&gt;

	&lt;span class=&quot;identifiers&quot;&gt;
						&lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot;	Gold
&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;10.1007/s11357-025-01733-3&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1007/s11357-025-01733-3&quot;&gt;
									DOI
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;001518302900001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001518302900001&quot;&gt;
									WoS
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot;	Gold
&quot;&gt;
							
							&lt;a style=&quot;color:black&quot; title=&quot;246671&quot; target=&quot;_blank&quot; href=&quot;https://real.mtak.hu/246671&quot;&gt;
									REAL
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;105009094271&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-105009094271&quot;&gt;
									Scopus
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;40576911&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=40576911&amp;dopt=Abstract&quot;&gt;
									PubMed
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;https://link.springer.com/10.1007/s11357-025-01733-3&quot; target=&quot;_blank&quot; href=&quot;https://link.springer.com/10.1007/s11357-025-01733-3&quot;&gt;
									Egyéb URL
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_NONE&quot; title=&quot;	Nincs
&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;https://www.scopus.com/pages/publications/105009094271?origin=resultslist&quot; target=&quot;_blank&quot; href=&quot;https://www.scopus.com/pages/publications/105009094271?origin=resultslist&quot;&gt;
									Egyéb URL
							&lt;/a&gt;
						&lt;/span&gt;
	&lt;/span&gt;


	&lt;OnlyViewableByAuthor&gt;&lt;div class=&quot;ratings&quot;&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Complementary and Alternative Medicine&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Geriatrics and Gerontology&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Veterinary (miscellaneous)&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Aging&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Cardiology and Cardiovascular Medicine&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt;
    &lt;/div&gt;&lt;/OnlyViewableByAuthor&gt;


	&lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt;
		&lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 15&lt;/span&gt;
		| Független: 11
		| Függő: 4
		| Nem jelölt: 0
		| WoS jelölt: 8 
		|  Scopus jelölt:&amp;nbsp;8 
		|  WoS/Scopus jelölt:&amp;nbsp;9 
		|  DOI jelölt:&amp;nbsp;11 
		
	&lt;/div&gt;
    
    
	&lt;div class=&quot;publication-citation&quot;&gt;
		&lt;a target=&quot;_blank&quot; href=&quot;/api/publication?cond=citations.related;eq;36216117&amp;sort=publishedYear,desc&amp;sort=title&quot;&gt;
			Idézett közlemények száma: 9
		&lt;/a&gt;
	&lt;/div&gt;



    &lt;div class=&quot;mtid&quot;&gt;&lt;span class=&quot;long-pub-mtid&quot;&gt;Közlemény: 36216117&lt;/span&gt;
    | &lt;span class=&quot;status-data status-ADMIN_APPROVED&quot;&gt; 	Admin láttamozott
  &lt;/span&gt;
        
	
	
Forrás	 Idéző
	
	
    | &lt;span class=&quot;type-subtype&quot;&gt;Folyóiratcikk
			( Szakcikk
			
			)
		&lt;/span&gt;
      		| &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt;
	| &lt;span class=&quot;publication-sourceOfData&quot;&gt;PubMed XML&lt;/span&gt;
&lt;/div&gt;

&lt;div class=&quot;funder&quot;&gt; (National Institute of Neurological Disorders and Stroke (R01NS100782)),    (FK147194),    Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015) Támogató: NKFIH,    (TKP2021-NKTA-47),    Nemzeti Kardiovaszkuláris Laboratórium(RRF-2.3.1-21-2022-00003) Támogató: NKFIH,    (TKCS-2021/32)   &lt;/div&gt;
&lt;div class=&quot;lastModified&quot;&gt;Utolsó módosítás: 2026.05.18. 16:40 Sonnevend Kinga (SE_AOK_Adm5_Élet_kutcsop, admin)
&lt;/div&gt;




	&lt;pre class=&quot;comment&quot; style=&quot;margin-top: 0; margin-bottom: 0;&quot;&gt;&lt;u&gt;Megjegyzés&lt;/u&gt;: Funding Agency and Grant Number: Semmelweis University; ELIXIR Hungary
            Funding text: The 4.0 version of ChatGPT, developed by OpenAI, and Gemini, developed by Google, were used as a tool to refine our writing and enhance the clarity of our work. The authors acknowledge the support of ELIXIR Hungary (www.bioinformatics.hu).&lt;/pre&gt;

&lt;/div&gt;&lt;/div&gt;</template2>
    </publication>
  </content>
</myciteResult>
